Biopolitics for the 21st Century
By Marcy Darnovsky,
2020 Science
| 12. 14. 2009
Much appreciation is due to Andrew for his courage in soliciting "alternative perspectives" on technology innovation and life in the 21st century. I can't help but observe that his nervousness about doing so is one small sign that something is amiss in what he calls "the interface between emerging technologies and society."
One challenge we face in mending that interface is a tendency toward over-enthusiasm about prospective technologies. Another is the entanglement of technology innovation and commercial dynamics. Neither of these is brand new.
Back in the last century, the 1933 Chicago World's Fair took "technological innovation" as its theme and "A Century of Progress" as its formal name. Its official motto was "Science Finds, Industry Applies, Man Conforms."
The slogan shamelessly depicts "science" and "industry" as dictator - or at least drill sergeant - of humanity. It anoints industrial science as a rightful decision-maker about human ends, and an inevitable purveyor of societal uplift.
Today the 1933 World's Fair slogan seems altogether crass. But have we earned our cringe? We'd like to think that we're more realistic about science...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Eric Schmidt, TIME | 04.16.2024
Imagine a world where everything from plastics to concrete is produced from biomass. Personalized cell and gene therapies prevent pandemics and treat previously incurable genetic diseases. Meat is lab-grown; enhanced nutrient grains are climate-resistant. This is what the future could...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Jorge Barrera and Rachel Houlihan, CBC | 04.09.2024
A Canadian DNA laboratory knowingly delivered prenatal paternity test results that routinely identified the wrong biological fathers — ruling out the real dads — and left a trail of shattered lives around the globe, a CBC News investigation has found...